Argo Biopharma Doses First Patient in BW-41012 Trial
SHANGHAI, China & NEW YORK, July 20, 2026 Argo Biopharma has announced the successful dosing of the first participant...
ischemic stroke
Advertisement
Sensome Advances Smart Guidewire Technology for Stroke Treatment
PARIS, France, May 20, 2026 Sensome continues to expand the clinical and commercial development of its smart guidewire platform...
J&J Expands Stroke Care with CEREGLIDE System
IRVINE, Calif., February 26, 2026 Johnson & Johnson announced the U.S. launch of CEREGLIDE™ 42, CEREGLIDE™ 57 aspiration catheters,...
Asundexian Shows 26% Stroke Risk Reduction in Phase III
Dateline – New Orleans, USA, Feb. 5, 2026 — Bayer announced that its investigational oral Factor XIa inhibitor asundexian...
Advertisement
